For decades, microbiologists have done their work by hand even as robotics and automation began to improve other laboratory processes. Until recently, the delicate techniques necessary to introduce mechanisms to microorganism study and analysis have been challenging for these divisions to automate. Now that's changing.
ARUP recently rolled out a next generation UM dashboard for clients—hospitals and healthcare organizations—that will allow them to further mine this data and make it actionable.
Ortho Clinical Diagnostics announced that, for the third year in a row, the Ortho Care™ service and support program was the highest-ranked original equipment manufacturer for overall service performance in the diagnostics industry.
In recognition of the need for a national coordinated and collective response to the epidemic of opioid addiction in the U.S., the Federation of State Medical Boards (FSMB) is partnering with the National Academy of Medicine (NAM) and 35 organizations to form the Action Collaborative on Countering the U.S. Opioid Epidemic. The public-private partnership is made up of organizations representing federal, state, and local governments, health systems, associations and provider groups, health education and accrediting institutions, pharmacies, payers, industry, nonprofits, and academia.
A neuroscientist from FAU has been conducting ground-breaking work on the basic mechanisms and the biochemical basis of chronic pain and drug addiction that have opened new avenues of research and identified novel drug targets to address both of these widespread disorders.
Performance Motion Devices today announced that its ATLAS® digital amplifiers, featuring the highest power density in the industry, can now be used with third party microprocessors or field programmable gate arrays (FPGAs) via Serial Peripheral Interface (SPI) communications.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced it was selected for a gold-level Edison Award™ in the Best New Product Awards™ category for its VITROS® NEPHROCHECK® Test
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator (VITROS® HIV Combo test) received approval from the U.S. Food and Drug Administration for use on Ortho’s VITROS 3600 Immunodiagnostic System
Ortho Clinical Diagnostics received approval from the U.S. Food and Drug Administration for Ortho’s VITROS® Immunodiagnostic Products HBeAg Assay and the VITROS® Immunodiagnostic Products Anti-HBe Assay for use on the VITROS® 3600 Immunodiagnostic System and VITROS® 5600 Integrated System
Ortho Clinical Diagnostics announced that its VITROS® NEPHROCHECK® test received CE Mark. The VITROS® NEPHROCHECK® test is the first fully automated risk assessment tool for predicting Acute Kidney Injury (AKI), a serious and potentially fatal condition affecting hospital patients worldwide
Ortho Clinical Diagnostics’ VITROS® XT 7600 Integrated System received CE Mark. By combining Ortho’s proprietary dry slide technology with sophisticated digital imaging and the potential to perform two separate lab tests simultaneously, Ortho introduces digital chemistry to clinical lab management
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced an international distribution and co-promotion agreement with Thermo Fisher Scientific to provide 14 assays used to monitor therapeutic drugs, immunosuppressive drugs and drugs of abuse.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it will officially unveil the VITROS® XT 7600 Integrated System, now available in numerous countries that accept CE Mark, at the 2018 AACC Annual Scientific Meeting & Clinical Lab Expo
Sysmex, one of the fastest growing providers of diagnostic hardware and software in the U.S., celebrates its 50th anniversary in booth number 1231 at this year’s annual meeting of the American Association for Clinical Chemistry (AACC). The company is also sharing its plans to equip the clinical laboratory of the future with innovative solutions in flow cytometry, urinalysis and hematology.
Responding to customer requirements to handle increased volumes in decentralized clinical testing, MedTest Dx today announced the introduction of its BA-800M Clinical Analyzer for general chemistry with a full line of reagents and the launch of its BC-5390 5-Part Differential Hematology Analyzer at the 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting.
Fujirebio Diagnostics, Inc., a consolidated subsidiary of Miraca Holdings Inc., has received U.S. Food and Drug Administration (FDA) clearance of the company’s Lumipulse® G B•R•A•H•M•S PCT Assay for testing on its LUMIPULSE® G1200 immunoassay platform.
Fujirebio Inc., a consolidated subsidiary of Miraca Holdings Inc., (Head office: Shinjuku-ku, Tokyo, President and CEO: Yoshihiro Ashihara, hereinafter “Fujirebio” or “the Company”) announced today that it has entered into an agreement with US-based Janssen Pharmaceuticals, Inc. (hereinafter “Janssen”) to develop and commercialize an AMYLOID β 42/40 RATIO assay.
MedTest Holdings, the solution provider of choice offering integrated products and services for decentralized clinical diagnostic testing, today announced the debut of its new corporate name—MedTest Dx—at the upcoming 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting.
Brandwidth Solutions, LLC, a full-service marketing agency addressing science-based businesses, has been recognized as Best Specialist Life Science Marketing Agency 2018-Pennsylvania by AI Global Media.
Debra Harrsch, founder and chief executive of Brandwidth Solutions, a full-service marketing agency addressing science-based businesses, received a Management Consulting Award from CEO Today magazine. The international publication “identifies the most hard-working and outstanding consultancy experts across the globe.”
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), has awarded the University of California, Irvine School of Medicine, a 4-year, $9 million grant aimed at determining the long-term impact of cannabis exposure on the adolescent brain.
Hahn-Schickard enables complex clinical pictures to be diagnosed quickly and reliably directly at the point of care. The latest device generation allows the amplification of RNA and DNA by means of fast PCR in 20 - 25 minutes. This makes it possible, for example, to analyze a real patient sample fully automatically in 30 minutes. The device can also be used in the field of food analysis or environmental analysis.
PixCell is a cell based diagnostics company that has developed the HemoScreen: the first true Point of Care (POC) Hematology analyzer that uses a self-contained disposable cartridge, preventing the need for any maintenance or calibrations. The HemoScreen is a portable and user-friendly test device that provides lab accurate results for the standard 20 Complete Blood Count (CBC) parameters, including a 5-part differential.
NAMSA®, the world’s only Medical Research Organization (MRO) that accelerates medical device development through integrated laboratory testing, clinical research and regulatory consulting services, announced today the launch of its in vitro diagnostic (IVD) development business to provide global manufacturers a proven resource for expedited commercialization outcomes delivered via NAMSA’s “Uniquely IVD” regulatory, quality and clinical research services.
Equitech Enterprises Inc. is leading supplier of quality human blood, human blood components, and biological fluids to the research industry.
Techcyte Europe has been awarded the 2018 Healthcare Startup of the Year at the annual Healthcare Summit in Luxembourg.
Magnefy offer an additional performance-driven solid phase for magnetic particle-based assays and isolations, including SPRI-based* total DNA isolation. (*Solid phase reversible immobilization, which features the isolation of high-purity nucleic acid in the presence of NaCl and PEG.)
Festo AACC 2018 News -- Festo introduces its next generation liquid handling/modular dossing system. Booth #462
Equitech-Bio, Inc will attend and participate in AACC 2018 at Booth #3971.
Dynex Technologies announced today it has finalized a supply agreement with ZEUS Scientific (Branchburg, NJ) enabling ZEUS to sell Dynex instruments to the global clinical market.
The American Thoracic Society led 10 medical professional organizations in filing an amicus brief last week regarding the FDA’s failure to apply pre-market review to new tobacco products. The brief was submitted in support of the American Academy of Pediatrics and its co-plaintiffs and outlines the compelling data indicating that the FDA’s failure to act harms children.
Enzo is pleased to announce the launch of a new primary antibody validated for IHC, our p16INK4a monoclonal antibody. Our antibody is specific to the p16INK4A protein, a cyclin-dependent kinase inhibitor that plays an important regulatory role in the cell cycle.
IDEX Health & Science Announces Acquisition of Finger Lakes Instrumentation
GenPrime Inc., a leading provider of digital technology platforms and lateral flow readers, has announced the development of a new handheld version of its FDA-cleared diagnostic test reader...
GenPrime Inc., a leading provider of digital technology platforms and lateral flow readers, has announced the development of a new high-throughput version of its FDA-cleared diagnostic test reader...
Web Industries Inc., a leading medical contract manufacturing organization (CMO), will highlight its commitment to building lasting relationships with medical device makers as well as enhanced manufacturing capabilities for lateral flow immunoassay (LFI) devices.
Artel, is featuring a new demonstration at the 70th AACC Annual Scientific Meeting (Jul. 29 – Aug. 2). They will demonstrate how combining volume verification technology with a precise automated liquid handler can provide an optimized NGS workflow – speeding the process and eliminating doubt.
epMotion 5075 NGS solution comes with a new set of software features that was specifically developed for NGS customer needs, like intelligent selection of single and 8-channel dispensing tools, flexible number of samples, reduced dead-volume, more worktable capacity, email notification and more.
Two new centrifuges from Eppendorf: the smaller benchtop centrifuges with up to 24 spaces herald a new era, while Eppendorf is simultaneously expanding the product range of its large refrigerated benchtop centrifuges with a particularly versatile, high-capacity variant.
Published in Addiction, a new paper lays out some of the factors that lead policymakers to look for easy answers to complex problems related to opioid addiction.
Patients who sought care for a sprained ankle in states that were found to be "high prescribers" of opioids were approximately three times more likely to receive a prescription for the drugs than those treated in "low-prescribing" states, according to new research. Additional results of the study show that patients who received prescriptions for long courses of the drugs (e.g. more than 30 tablets of oxycodone 5 mg) were five times more likely to fill additional opioid prescriptions over the next 6 months than those who received just a few days' supply (e.g. 10 tablets of less).
ALPCO, a leading producer of research and clinical immunoassays, has announced the upcoming launch of its FDA Class I Exempt STELLUX® Chemi Glucagon ELISA.
Visiun, the leader in laboratory analytics, will be showcasing the latest advancements in laboratory analytics at the 2018 AACC Clinical Lab Expo. Visit Visiun at booth 4367 at McCormick Place in Chicago, Illinois, from July 31 – August 2 to discover why hundreds of laboratories across the United States and Canada select Visiun’s Performance Insight® as their tool of choice for laboratory analytics.
Biotin supplementation, in the common dosage of 10 mg per day, can interfere with immunoassays leading to incorrect laboratory results and the potential for clinical misinterpretation.
This year at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, we look forward to showing our latest u-CupTM product line of Point-of-Care Drug testing cups.
Advanced Data Systems Corporation (ADS) is pleased to announce that its MedicsPremier system, a leading, innovative billing and reporting software solution for laboratories has been enhanced with a built-in utility for managing and reporting on laboratory sales activities and commissions.
Japan’s lawmakers on Friday approved the nation’s first integrated resorts; IGI reports offered analysis for officials, business leaders on gaming regulation and ways to balance growing tourism market while minimizing social costs.
Artel, as the industry’s strongest proponent of the critical role of liquid handling in achieving optimized assay results and improved laboratory productivity, is featuring a new demonstration at the 70th AACC Annual Scientific Meeting in Chicago (July29th – August 2nd).
While many people consider drinking to be a pleasurable activity at home or in social venues with friends, it can result in harm to the user and to others who are affected by the user’s drinking. These harms can include inter-personal violence, fetal alcohol spectrum disorders (FASDs), emotional neglect, and social embarrassment, which can adversely affect close relationships, such as with family, and extended relationships, such as with friends, co-workers, and more distant relatives. This study analyzed the impact of having close- and extended-proximity relationships with a harmful drinker among men and women in 10 countries.
Biomat has added to its line of coated 96 well microplates a line of PCR supports
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right